[ASAP] Utilizing Machine Learning to Improve Neutralization Potency of an HIV-1 Antibody Targeting the gp41 N-Heptad Repeat LikeLiked Date: June 20, 2025 Less than 1 MinRead Views: 24 ACS Chemical Biology DOI: 10.1021/acschembio.5c00035 Source: http://dx.doi.org/10.1021/acschembio.5c00035 FacebookTwitterLinkedinWhatsAppTelegramEmail ALT-Lab-Ad-1ALT-Lab-Ad-2ALT-Lab-Ad-3ALT-Lab-Ad-4ALT-Lab-Ad-5ALT-Lab-Ad-6ALT-Lab-Ad-7ALT-Lab-Ad-8ALT-Lab-Ad-9ALT-Lab-Ad-10ALT-Lab-Ad-11ALT-Lab-Ad-12ALT-Lab-Ad-13 Recent Articles Charted: China’s Rise to Energy Superpower Energy June 15, 2026 Ranked: The Biggest U.S. Companies by Revenue Finance & investments June 15, 2026 Know When Electricity Costs Less for You and the Planet Carbon Markets June 15, 2026 Industry Ag News 6/15 Food & Agriculture June 15, 2026 Continental develops bespoke tire for Renault that delivers up to 35% lower rolling resistance Clean Tech June 15, 2026 FIA extends Pirelli’s Formula 1 tire supply deal to 2028 Clean Tech June 15, 2026 Advancing sustainability through eco-design in the circular economy: A bibliometric analysis Research June 15, 2026 MNRE Clarifies ALMM List-II Exemption Process For Delayed Rooftop Solar Projects Solar Power June 15, 2026 Chinese Firms Back Oman’s Green Energy And Cybersecurity Ambitions With Major Investments Solar Power June 15, 2026 Compound Solutions Recognized as a Great Place To Work® for Sixth Consecutive Year Materials & Chemicals June 15, 2026 Load more